135 related articles for article (PubMed ID: 14743872)
41. Use of alkaline Comet assay to assess DNA repair after m-THPC-PDT.
Rousset N; Keminon E; Eléouet S; Le Néel T; Auget JL; Vonarx V; Carré J; Lajat Y; Patrice T
J Photochem Photobiol B; 2000 Jul; 56(2-3):118-31. PubMed ID: 11079472
[TBL] [Abstract][Full Text] [Related]
42. Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice.
Morlet L; Vonarx-Coinsmann V; Lenz P; Foultier MT; de Brito LX; Stewart C; Patrice T
J Photochem Photobiol B; 1995 Apr; 28(1):25-32. PubMed ID: 7791003
[TBL] [Abstract][Full Text] [Related]
43. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
Mitra S; Foster TH
Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
[TBL] [Abstract][Full Text] [Related]
44. Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.
Kukcinaviciute E; Sasnauskiene A; Dabkeviciene D; Kirveliene V; Jonusiene V
Photochem Photobiol Sci; 2017 Jul; 16(7):1063-1070. PubMed ID: 28509917
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effect of heat shock protein 70 on apoptosis induced by photodynamic therapy in vitro.
Nonaka M; Ikeda H; Inokuchi T
Photochem Photobiol; 2004 Jan; 79(1):94-8. PubMed ID: 14982037
[TBL] [Abstract][Full Text] [Related]
46. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.
Ris HB; Altermatt HJ; Inderbitzi R; Hess R; Nachbur B; Stewart JC; Wang Q; Lim CK; Bonnett R; Berenbaum MC
Br J Cancer; 1991 Dec; 64(6):1116-20. PubMed ID: 1764375
[TBL] [Abstract][Full Text] [Related]
47. Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin.
van Geel IP; Oppelaar H; Oussoren YG; van der Valk MA; Stewart FA
Int J Cancer; 1995 Jan; 60(3):388-94. PubMed ID: 7829249
[TBL] [Abstract][Full Text] [Related]
48. Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro.
Gyenge EB; Hiestand S; Graefe S; Walt H; Maake C
Photodiagnosis Photodyn Ther; 2011 Jun; 8(2):86-96. PubMed ID: 21497299
[TBL] [Abstract][Full Text] [Related]
49. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
50. Heat shock protein 70 is acute phase reactant: response elicited by tumor treatment with photodynamic therapy.
Merchant S; Korbelik M
Cell Stress Chaperones; 2011 Mar; 16(2):153-62. PubMed ID: 20865355
[TBL] [Abstract][Full Text] [Related]
51. Differential GFP expression patterns induced by different heavy metals in Tg(hsp70:gfp) transgenic medaka (Oryzias latipes).
Ng GH; Xu H; Pi N; Kelly BC; Gong Z
Mar Biotechnol (NY); 2015 Jun; 17(3):317-27. PubMed ID: 25652692
[TBL] [Abstract][Full Text] [Related]
52. Effects of HSP27 downregulation on PDT resistance through PDT-induced autophagy in head and neck cancer cells.
Kim J; Lim H; Kim S; Cho H; Kim Y; Li X; Choi H; Kim O
Oncol Rep; 2016 Apr; 35(4):2237-45. PubMed ID: 26820233
[TBL] [Abstract][Full Text] [Related]
53. Photodynamic therapy in 2D and 3D human cervical carcinoma cell cultures employing LED light sources emitting at different wavelengths.
Etcheverry ME; Pasquale MA; Bergna C; Ponzinibbio C; Garavaglia M
Phys Med Biol; 2020 Jan; 65(1):015017. PubMed ID: 31739296
[TBL] [Abstract][Full Text] [Related]
54. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
55. Elevation of GRP-78 and loss of HSP-70 following photodynamic treatment of V79 cells: sensitization by nigericin.
Xue LY; Agarwal ML; Varnes ME
Photochem Photobiol; 1995 Jul; 62(1):135-43. PubMed ID: 7638257
[TBL] [Abstract][Full Text] [Related]
56. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic therapy using mTHPC for malignant disease in the oral cavity.
Fan KF; Hopper C; Speight PM; Buonaccorsi GA; Bown SG
Int J Cancer; 1997 Sep; 73(1):25-32. PubMed ID: 9334805
[TBL] [Abstract][Full Text] [Related]
58. Chlorin Nanoparticles for Tissue Diagnostics and Photodynamic Therapy.
Scalfi-Happ C; Zhu Z; Graefe S; Wiehe A; Ryabova A; Loschenov V; Wittig R; Steiner RW
Photodiagnosis Photodyn Ther; 2018 Jun; 22():106-114. PubMed ID: 29567384
[TBL] [Abstract][Full Text] [Related]
59. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
Yu YA; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
[TBL] [Abstract][Full Text] [Related]
60. Promotion of photodynamic therapy-induced apoptosis by the mitochondrial protein Smac/DIABLO: dependence on Bax.
Usuda J; Chiu SM; Azizuddin K; Xue LY; Lam M; Nieminen AL; Oleinick NL
Photochem Photobiol; 2002 Aug; 76(2):217-23. PubMed ID: 12194220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
